Patents by Inventor Zenghui Yu

Zenghui Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230133273
    Abstract: Embodiments of the present disclosure disclose a computing device, and are applied to the field of computing devices. In the present disclosure, a virtual interrupt obtained by a host machine is mapped to a physical interrupt of a physical layer, and a virtual interrupt identifier corresponding to the physical interrupt is transferred to a virtual processor by using the physical layer. When a hardware layer transparently transmits the virtual interrupt identifier to the virtual processor, the virtual processor does not need to exit. This decreases a delay caused by exit of the virtual processor when software implements virtual interrupt routing.
    Type: Application
    Filed: December 27, 2022
    Publication date: May 4, 2023
    Inventors: Haibin WANG, Zenghui YU, Jian MA
  • Patent number: 9199983
    Abstract: Disclosed are 3-aryl-6-aryl-[1,2,4]triazolo[4,3-a]pyridines thereof, represented by the Formula (I) wherein Ar1, Ar2, R1-R3 are defined herein. Compounds having Formula (I) are inhibitors of cell proliferation. Therefore, compounds of the invention may be used to treat clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: December 1, 2015
    Inventors: Suixiong Cai, Ye Edward Tian, Haijun Dong, Lei Chen, Zenghui Yu, Feng Yin, Sheng Bi, Lijun Liu, Lizhen Wu
  • Publication number: 20130280245
    Abstract: Disclosed are 3-aryl-6-aryl-[1,2,4]triazolo[4,3-?]pyridines thereof, represented by the Formula (I) wherein Ar1, Ar2, R1—R3 are defined herein. Compounds having Formula (I) are inhibitors of cell proliferation. Therefore, compounds of the invention may be used to treat clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
    Type: Application
    Filed: November 16, 2011
    Publication date: October 24, 2013
    Applicant: IMPACT Therapeutics, Inc.
    Inventors: Suixiong Cai, Ye Edward Tian, Haijun Dong, Lei Chen, Zenghui Yu, Feng Yin, Sheng Bi, Lijun Liu, Lizhen Wu